Inflammatory Cell Numbers in the Stomach of Japanese Subjects with Endoscopically Normal Mucosa without Helicobacter pylori Infection

Abstract

Introduction: Since inflammatory cells, such as lymphocytes and plasma cells, normally inhabit the stomach, the border between normal and mild inflammation is difficult to visually determine using the updated Sydney system scale of gastritis. Additionally, eosinophils in the gastric mucosa must be counted to diagnose eosinophilic gastritis. We aimed to determine the normal number of inflammatory cells in patients with endoscopically normal mucosa and without H. pylori infections. Methods: We assessed patients aged 20–79 years, who had undergone upper gastrointestinal endoscopy at Kawasaki Medical School Hospital between January 2010 and December 2014. Inflammatory cells were counted in 1,000 μm2 fields of pyloric and fundic gland mucosal biopsy specimens. We finally included 325 (male, n = 141; female, n = 184; average age = 49.3 years) patients without inflammation who had H. pylori-negative endoscopic results and negative histological findings interpreted based on the updated Sydney System and the Kyoto classification of gastritis. Results: The average numbers of nucleated cells were 83.3 ± 14.2/mm2 and 65.4 ± 12.6/mm2 in the pyloric and fundic gland mucosae, respectively. Inflammatory cells were significantly more abundant in the pyloric mucosa than the fundic gland mucosa (p < 0.05). Age and sex distribution did not significantly differ. Eosinophils were absent or scanty in the gastric mucosae of both glands in all patients. Conclusion: We determined the absolute values of inflammatory cells, including eosinophils, in normal mucosae of pyloric and fundic glands. These findings could be important in defining gastric mucosal inflammation, including eosinophilic gastritis diagnosis.

Management ofHelicobacter pyloriinfection: the Maastricht VI/Florence consensus report

“…In the absence of H. pylori the gastric mucosa does not demonstrate signs of chronic active inflammation, neutrophils are absent and infiltration with mononuclear cells is minor. [8][9][10] Therefore, an agent causing such changes in the gastric mucosa cannot be considered part of the normal microbiota and the fact that H. pylori has coinhabited mankind for millennia does not preclude its pathogenicity of today. 11 Koch's postulate for pathogenicity has been documented since the early days of H. pylori discovery.…”

Randomised clinical trial: 3-year interim analysis results of the VISION trial to evaluate the long-term safety of vonoprazan as maintenance treatment in patients with erosive oesophagitis

“…Interestingly, in this study, improvement in inflammation and atrophy was observed in both vonoprazan and lansoprazole groups. Although normally there is no inflammation or atrophy of the gastric mucosa in H. pylori -uninfected subjects [ 62 ], gastric mucosal inflammation was observed at the start of treatment in 23.1% of antrum and 36.6% of corpus in the vonoprazan group and 26.9% of antrum and 43.3% of corpus in the lansoprazole group. In addition, at the start of the treatment, gastric biopsies showed atrophy of the antrum in 42.5% and 38.8% of patients in the vonoprazan and lansoprazole groups, respectively.…”

H. pylori-associated chronic gastritis: status update on the problem

“…Многочисленными исследованиями показано, что ведущим этиологическим фактором ХГ является инфекция Helicobacter pylori (H. pylori) [1][2][3]. При отсутствии факта инфицирования слизистая желудка не проявляет морфологических признаков хронического активного воспаления, инфильтрация нейтрофилами отсутствует, а лоцирование мононуклеарных клеток незначительно [4,5]. Учитывая этот факт, экспертным советом последнего консенсуса Маастрихт VI 2022 г. рекомендовано рассматривать H. pylori как патоген, инфицирование которым всегда приводит к развитию ХГ [6].…”